Quest Diagnostics, Inc. (DGX) Misses Q3 EPS by 18c; Trims Outlook
Quest Diagnostics, Inc. (NYSE: DGX) reported Q3 EPS of $1.02, $0.18 worse than the analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
